HEPATITIS C PATIENT INFO - What You MUST Know (Hepatitis C Treatment Options)

HEPATITIS C PATIENT INFO - What You MUST Know
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on

Apath,LLC | HCV Replicon
Apath is pleased to announce the availability of an HCV replicon system for use in antiviral discovery research programs. Apath possesses both a highly robust

Casia's HCV Poetry
To read any of the HCV-related poetry I have included here, simply click on its title. The poems are listed chronologically, with the newest stuff at the bottom

Home
The symposium has provided one of the most important opportunities for virologists in the field of HCV and related viruses to present their scientific work to the largest possible international

America's Blood Centers :: HCV Lookback
Statement of support for blood safety measures, including HCV Lookback. 1-888-USBLOOD